Completed PHASE4 INTERVENTIONAL 3-arm NCT03892668

Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy.

Safety and Efficacy of Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy; A Randomized Controlled Trial

Sponsor: Cairo University

Conditions Myomectomy

Interventions Tranexamic Acid oxytocin placebo

Updated 5 times since 2019 Last updated: Apr 26, 2020 Started: Apr 30, 2019 Primary completion: Feb 1, 2020 Completion: Mar 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Myomectomy and is currently completed. Cairo University leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
May 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Not Yet Recruiting → Completed
Apr 2019 — May 2020 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Giza, Egypt